Cell
Volume 181, Issue 2, 16 April 2020, Pages 271-280.e8
Article
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
open access
Graphical Abstract
Keywords
SARS-CoV-2
COVID-19
ACE2
TMPRSS2
spike
entry
neutralization
coronavirus
priming
Cited by (0)
© 2020 Elsevier Inc.